employee
employee
employee
68.41
Ectoparasitoses are widespread in nature and have a negative impact on their health and quality of life in dogs, exacerbate chronic diseases and reduce immunity. In addition, their pathogens are carriers of many natural diseases. For the complex and most effective treatment and prevention of ectoparasitosis, the use of systemic drugs is most preferable, it is to this type of drugs that the new medicinal product for veterinary use Vepripak ® from Vetstem LLC belongs. The main active ingredient of Vepripak ® is a fluorolaner, which has high insecto-acaricidal activity and is characterized by a long protective period. The aim of this study is to compare the therapeutic efficacy, safety and digestibility of the drug Vepriak®, with similar characteristics of the reference drug Bravecto®.
ectoparasitoses, ixodid ticks, dogs, babesiosis, flourolaner, Vepripak®, Bravecto®
1. Gassel, M. The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity / M. Gassel, C. Wolf, S. Noack, H. Williams, T. Ilg // Insect Biochem Mol Biol. ‒ 2014. ‒ pp. 111-24. Doi:https://doi.org/10.1016/j.ibmb.2013.11.009.
2. Walther, F.M. The effect of food on the pharmacokinetics of oral fluralaner in dogs / F.M. Walther, M.J. Allan, R.K. Roepke, M.C. Nuernberger // Parasit Vectors. ‒ 2014. ‒ 7:84. Doi:https://doi.org/10.1186/1756-3305-7-84.
3. Walther, F.M. Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration / F.M. Walther, A.J. Paul, M.J. Allan, R.K. Roepke, M.C. Nuernberger // Parasit Vectors. ‒ 2014. ‒ No.7. ‒ pp. 86. Doi:https://doi.org/10.1186/1756-3305-7-86.
4. Kilp, S. Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration / S. Kilp, D. Ramirez, M.J. Allan, R.K. Roepke, M.C. Nuernberger // Parasit Vectors. ‒ 2014. ‒ No. 7. ‒ pp. 85. Doi:https://doi.org/10.1186/1756-3305-7-85.
5. Meadows, C. A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations / C. Meadows, F. Guerino, F. Sun // Parasit Vectors. ‒ 2014. ‒ No. 7. ‒ pp. 375. Doi:https://doi.org/10.1186/1756-3305-7-375.
6. Taenzler, J. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets / J. Taenzler, J. Liebenberg, R.K. Roepke, A.R. Heckeroth // Parasit Vectors. ‒ 2015. ‒ No. 8. ‒ pp. 305. Doi:https://doi.org/10.1186/s13071-015-0923-1.
7. Pfister, K. Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs / K. Pfister, R. Armstrong // Parasit Vectors. ‒ 2016. ‒ No. 9(1). ‒ pp. 436. Doi:https://doi.org/10.1186/s13071-016-1719-7.